CAV regimen
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords:CAV Regimen; Cytoxan-Adriamycin-Vincristine Regimen; VAC Regimen
Overview
Overview
CAV regimen refers to a regimen consisting of cyclophosphamide, doxorubicin and vincristine used for the treatment of extensive-stage small cell lung cancer.[1][2]
Regimen
Regimen
CCyclophosphamide
ADoxorubicin (Adriamycin)
VVincristine
References
References
- ↑ “NCI Thesaurus”.
- ↑ “R-CHOP – National Cancer Institute”.
- ↑ Kawahara M, Tsuruta M, Furuse K, Arai R, Kodama N, Yamamoto M; et al. (1988). “[Cyclophosphamide, adriamycin and vincristine (CAV) in the treatment of small cell lung cancer]”. Gan To Kagaku Ryoho. 15 (3): 457–62. PMID 2831819.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH